Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Instil Bio, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of TIL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders43238−3
Shares5.25M5.16K4.65M−597.0K (−11.4%)
Value$91.2M$89.6K$96.9M+$5.77M (+6.3%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Instil Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to TIL in Q2 2025
InstitutionSharesValue% of portfolio
Sectoral Asset Management Inc86,220$1.80M1.19%
Northern Trust Corp64,413$1.34M0.00%
Macquarie Group Ltd50,000$1.04M0.00%
Trexquant Investment LP17,369$361.8K0.00%
Exome Asset Management LLC16,200$337.4K0.28%
Americana Partners, LLC12,926$269.2K0.01%
GF Fund Management Co. Ltd.3,000$62.5K0.00%
Raymond James Financial Inc1,433$29.9K0.00%
Royal Bank of Canada335$7.00K0.00%

Sold out (12)

Institutions that held Instil Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of TIL in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
OrbiMed Advisors LLC116,785$2.03M
Velan Capital Investment Management LP69,000$1.20M
Adage Capital Partners GP, L.L.C.40,000$694.4K
VR Adviser, LLC33,177$576.0K
Fred Alger Management, LLC31,314$543.6K
ADAR1 Capital Management, LLC24,328$422.3K
Marshall Wace, LLP22,298$387.1K
Omers Administration Corp18,700$324.6K
Schonfeld Strategic Advisors LLC13,864$240.7K
Acadian Asset Management LLC13,490$233.0K
Palo Alto Investors LP11,165$193.8K
Susquehanna International Group, LLP10,511$182.5K

Not filed for Q2 2025 yet (2)

Institutions that held Instil Bio, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TIL in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Pinpoint Asset Management Ltd5,094$88.4K
Lindbrook Capital, LLC68$1.18K